VNE EN# #HE PRACTICE
Corresponding Author: CAPT Arthur Wen- del, Medical O cer, Environmental Medi- cine and Health Systems Intervention Sec- tion, O ce of Capacity Development and Applied Prevention Science, Agency for Toxic
American Cancer Society. (2020). Can kidney cancer be found early? https://www.cancer. org/cancer/types/kidney-cancer/detection- diagnosis-staging/detection.html Barocas, D.A., Boorjian, S.A., Alvarez, R.D., Downs, T.M., Gross, C.P., Hamilton, B.D., Kobashi, K.C., Lipman, R.R., Lotan, Y., Ng, C.K., Nielsen, M.E., Peterson, A.C., Raman, J.D., Smith-Bindman, R., & Souter, L.H. (2020). Microhematuria: AUA/SUFU guideline. Journal of Urology , 204 (4), 778–786. https://doi.org/10.1097/ ju.0000000000001297 Barry, V., Winquist, A., & Steenland, K. (2013). Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environmental Health Perspectives , 121 (11–12), 1313–1318. https://doi.org/10.1289/ehp.1306615 Cumberbatch, M.G., Rota, M., Catto, J.W.F., & La Vecchia, C. (2016). The role of tobacco smoke in bladder and kidney carcinogen- esis: A comparison of exposures and meta- analysis of incidence and mortality risks. European Urology , 70 (3), 458–466. https:// doi.org/10.1016/j.eururo.2015.06.042 Gray, R.E., & Harris, G.T. (2019). Renal cell carcinoma: Diagnosis and manage- ment. American Family Physician , 99 (3), 179–184. Medical Panel for the C-8 Class Members. (2013). Information on the C-8 (PFOA) medical monitoring program screening tests . http://www.c-8medicalmonitoringprogram. com/docs/med_panel_education_doc.pdf Raleigh, K.K., Alexander, B.H., Olsen, G.W., Ramachandran, G., Morey, S.Z., Church, T.R., Logan, P.W., Scott, L.L.F., & Allen, E.M. (2014). Mortality and cancer incidence in ammonium perfluorooctanoate production workers. Occupational and Environmen- tal Medicine , 71 (7), 500–506. https://doi. org/10.1136/oemed-2014-102109
Scelo, G., & Larose, T.L. (2018). Epidemiol- ogy and risk factors for kidney cancer. Jour- nal of Clinical Oncology , 36 , 3574–3581. https://doi.org/10.1200/jco.2018.79.1905 Seretis, A., Cividini, S., Markozannes, G., Tseretopoulou, X., Lopez, D.S., Ntzani, E.E., & Tsilidis, K.K. (2019). Association between blood pressure and risk of can- cer development: A systematic review and meta-analysis of observational studies. Sci- entific Reports , 9 , Article 8565. https://doi. org/10.1038/s41598-019-45014-4 Sharp, V.J., Barnes, K.T., & Erickson, B.A. (2013). Assessment of asymptomatic microscopic hematuria in adults. American Family Physician , 88 (11), 747–754. https:// www.aafp.org/pubs/afp/issues/2013/1201/ p747.html Shearer, J.J., Callahan, C.L., Calafat, A.M., Huang, W.-Y., Jones, R.R., Sabbisetti, V.S., Freedman, N.D., Sampson, J.N., Silver- man, D.T., Purdue, M.P., & Hofmann, J.N. (2020). Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma. Journal of the National Cancer Institute , 113 (5), 580–587. https:// doi.org/10.1093/jnci/djaa143 Siegel, R.L., Miller, K.D., Fuchs, H.E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians , 72 (1), 7–33. https://doi.org/10.3322/caac.21708 Steenland, K., & Woskie, S. (2012). Cohort mortality study of workers exposed to per- fluorooctanoic acid. American Journal of Epidemiology , 176 (10), 909–917. https:// doi.org/10.1093/aje/kws171 Vieira, V.M., Ho«man, K., Shin, H.-M., Wein- berg, J.M., Webster, T.F., & Fletcher, T. (2013). Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: A geographic analysis. Envi- ronmental Health Perspectives , 121 (3), 318– 323. https://doi.org/10.1289/ehp.1205829
Substances and Disease Registry. Email: arthur.wendel@cdc.hhs.gov.
References Adams, K.F., Leitzmann, M.F., Albanes, D., Kipnis, V., Moore, S.C., Schatzkin, A., & Chow, W.-H. (2008). Body size and renal cell cancer incidence in a large US cohort study. American Journal of Epidemiology , 168 (3), 268–277. https://doi.org/10.1093/ aje/kwn122 Agency for Toxic Substances and Disease Registry. (2018). Environmental health and medicine education . https://www.atsdr.cdc. gov/emes/index.html Agency for Toxic Substances and Disease Registry. (2021). Toxicological profile for perfluoroalkyls . U.S. Department of Health and Human Services. https://www.atsdr. cdc.gov/ToxProfiles/tp200.pdf Agency for Toxic Substances and Disease Registry. (2022). PFAS exposure assessments final report: Findings across ten exposure assessment sites . https://www.atsdr.cdc.gov/ pfas/docs/PFAS-EA-Final-Report-508.pdf Agency for Toxic Substances and Disease Registry. (2023). PFAS blood level estima- tion tool . https://www.atsdr.cdc.gov/pfas/ bloodlevelestimator/index.html Agency for Toxic Substances and Disease Registry. (2024a). PFAS information for cli- nicians—2024 . https://www.atsdr.cdc.gov/ pfas/resources/pfas-information-for-clini cians.html Agency for Toxic Substances and Disease Registry. (2024b). Per- and polyfluoroalkyl substances (PFAS) and your health . https:// www.atsdr.cdc.gov/pfas/index.html
According to the U.S. Census Bureau, there are more than 30 million swimmer visits each year in the U.S. We have a webpage of resources that can help you keep your communities safe, especially with the summer months approaching. For example, the Standard for Aquatic Facility Environments–Data (SAFE-D) model allows jurisdictions to accurately share and compare aquatic facility inspection data from numerous agencies. Learn more and explore our resources at www.neha.org/recreational-waters.
Did You Know?
34
Volume 86 • Num)er 10
Powered by FlippingBook